PNC Financial Services Group
BBNX

PNC Financial Services Group’s Beta Bionics BBNX Stock Holding History

PNC Financial Services Group’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$641 Sell
64
-36
-36% -$532 ﹤0.01% 4856
2025
Q4 		$3.05K Buy
100
+50
+100% +$1.33K ﹤0.01% 4417
2025
Q3 		$994 Hold
50
– – ﹤0.01% 4676
2025
Q2 		$728 Hold
50
– – ﹤0.01% 4619
2025
Q1 		$612 Buy
+50
New +$932 ﹤0.01% 4604

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group's BBNX Position: Q1 2026 in Review

PNC Financial Services Group reduced its Beta Bionics (BBNX) stake by 36% in Q1 2026, selling an estimated $532 and leaving 64 shares worth $641. The position accounts for ﹤0.01% of the portfolio, ranked #4856.

PNC Financial Services Group first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.05K in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • PNC Financial Services Group held 64 shares of Beta Bionics worth $641 as of Q1 2026.
  • PNC Financial Services Group sold 36 Beta Bionics shares in Q1 2026, an estimated $532.
  • Beta Bionics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4856 holding.
  • PNC Financial Services Group first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • PNC Financial Services Group's Beta Bionics position peaked at $3.05K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.